Analysis On The Choose Of Technical Innovation Model In Chinese Pharmaceutical Industy

In recent years, pharmaceutical manufacturing has been considerable development. It is hailed as a sunrise industry.Our Pharmaceutical Industry developed with great speed too. Since China entries into WTO, our Pharmaceutical Industry has become one of the fastest growing industries and has remarkable achievements. To maintain a sustainable competitive advantage, it needs continual technical innovation. Technical innovation contains self-reliant innovation and simulating innovation.In recent years, our country has been emphasizing innovation and building innovation-oriented country. It has issued documents constantly to make self-reliant innovation to the national innovation strategic level. However, from a global perspective, according to the current differences in innovative capacity, the world pharmaceutical industry is divided into four levels. Chinese pharmaceutical industry roughly is in the forefront of the second level, which has strong generic capable. Although since the1980s, Chinese pharmaceutical industry has been considerable development. It really has improved significantly in the production capacity and scale. But the Industrial innovation was not has a significant improvement with the rapid expansion of production capacity and scale. Chinese pharmaceutical industry's technology gap between advanced countries level is quite large.This paper is to study the contents:Chinese pharmaceutical industry should choose which technological innovation model, select the model of independent innovation, or recognize the reality, being selected to imitate innovation, as in Japan, when Technology accumulated to a certain extent and have independent innovation capacity,then gradually transition to independent innovation.This paper introduces the theory of technological innovation and the advantage of later theory, self-reliant innovation and Simulating Innovation, and their respective advantages and disadvantages and mutual relations firstly.Second, put the self-reliant innovation and Simulating Innovation into a same model, considering the character that pharmaceutical industry is close contact with the intellectual property rights, I put the Intellectual property in the analysis framework and get mathematical model. I analyze technology gap and intellectual property on the impact of technological innovation mode selection. Based on the theoretical model, I use econometric methods to constructed inter-provincial panel data model.According to the proportion of output value of pharmaceutical industry on the GDP,27provinces and cities in our country except Xizang,Xinjiang,Nixia,Qinghai are divided into two regions. Region one includesBeijing,Tianjin,Hebei,Jilin,Heilongjiang,Shanghai,Jiangsu,Zhejia ng,Jiangxi,Shandong,Hubei,Guangdong,Hainan,Chongqing,Sichuan,and Shanxi16provinces and autonomous regions and municipalities.The other region includes Shanxi Neimenggu, Liaoning, Anhui, Fujian, Henan,Hunan,Guizhou,Guangxi,Yunnan,Gansu11provinces. I study the two regions choose which technological innovation model respectively according to their own environment. I obtain the following results:The provinces in region one have a bigger proportion of output value of pharmaceutical industry on the GDP, the level of technology is relatively high and the technology gap is relatively small, It has passed to the initial stage of imitation which solely rely on technology purchases, introduction and digestion and absorption and should apply higher levels of imitation and self-reliant innovation. However, the provinces in region two are almost in middle and west region in China, technology gap is relatively large, the level of technology can't meet the requirement of self-reliant innovation and simulating innovation through FDI. They need to prompt their skills and increase the accumulation of technology through imitation. It doesn't have strength for self-reliant innovation.The last, for regional differences, the two regions should take a different pattern of technological innovation. The provinces in region one should create an environment conducive to self-reliant innovation to strengthen the independent innovation. For the provinces in region two, we should continue to strengthen the simulating innovation capacity to narrow the technology gap.